Near-term costs weigh on earnings, but BofA believes Lynas's long-term rare earth thesis and valuation appeal remain intact

Overview

The report reviews Lynas Rare Earths' FY26 results and their implications for medium- to long-term earnings and valuation. BofA believes operational disruptions at Kalgoorlie and Mt Weld, insufficient fixed-cost absorption, and higher depreciation, amortization, and financing expenses will depress near-term earnings. However, the company's position as a rare earth supplier outside China, government support, and long-term volume growth thesis remain intact, so it maintains its Buy rating.

Core views

FY26 results did not materially change the long-term view, but they revealed greater near-term cost pressure. The company reported FY26 adjusted EBITDA of A$402 million and reported EBITDA of A$386 million, with the former broadly in line with consensus. Net profit after tax was A$222 million, 8% below consensus, mainly because operating costs, depreciation and amortization, and financing expenses exceeded expectations. Q&A during the earnings call focused on future operational debottlenecking, the credibility of achieving long-term NdPr production of 12ktpa, heavy rare earth growth, feedstock sources, and downstream strategy. BofA therefore concludes that investors remain focused on long-term growth potential rather than earnings volatility in any single year. Because ramp-up costs arising from operational disruptions at Kalgoorlie and Mt Weld were higher than expected, BofA believes fixed costs cannot temporarily be fully absorbed based on nameplate capacity and assumes the company will not reach 12kt of production until FY29. Based on this assumption, its forecast for average TREO unit cash costs rises by 4.0% to A$40/kg. FY27-FY30 EBITDA forecasts are consequently lowered by 1%-5%; FY27, FY28, and FY29 EBITDA are reduced from A$788.1 million, A$984.5 million, and A$1,140.4 million to A$764.8 million, A$970.3 million, and A$1,085.0 million, respectively. Due to increased lease liabilities, BofA also raises depreciation, amortization, and financing costs, reducing FY27-FY30 EPS forecasts by an average of 12.0%; FY27, FY28, and FY29 EPS are lowered from A$0.59, A$0.65, and A$0.74 to A$0.52, A$0.58, and A$0.63, respectively. The updated financial model still reflects substantial growth. BofA expects sales to increase from A$978 million in FY26 to A$1,508 million in FY27, A$1,772 million in FY28, and A$2,140 million in FY29. Over the same period, EBITDA is expected to rise from A$402 million to A$765 million, A$970 million, and A$1,085 million, while net profit before exceptional items is forecast to increase from A$238 million to A$525 million, A$587 million, and A$636 million. Free cash flow is expected to be A$141 million in FY26, A$95 million in FY27, A$187 million in FY28, and A$600 million in FY29. The report forecasts a 14% EPS CAGR for FY27-FY30, indicating that near-term forecast reductions have not eliminated the medium-term earnings expansion trajectory. The long-term investment thesis rests on resource quality, supply scarcity, and policy support. Lynas owns the high-grade Mt Weld rare earth mine in Western Australia, operates downstream light rare earth separation facilities in Malaysia, and is building a heavy rare earth separation facility in the United States that is fully funded by the U.S. Department of Defense. The report describes it as the only listed rare earth producer of meaningful scale outside China and one of the few established suppliers outside China capable of producing both NdPr and Dy/Tb. BofA believes high-grade resources, an established market position, existing infrastructure, and access to low-cost financing constitute advantages over peers. Meanwhile, green-economy demand, the strategic and political importance of rare earths, and policy support from the United States, Australia, and Japan for supply chains outside China may allow this scarcity position to persist. Market expectations and share-price valuation have diverged. Supported by a 20% year-to-date increase in NdPr spot prices and protection from the US$110/kg JARE price floor, consensus FY27-FY31 EPS estimates have been raised during the year, as pricing has been sufficient to offset lower NdPr production forecasts. However, Lynas's consensus P/NPV has declined from 1.8x in October 2025 to 0.94x currently. The report believes the discount mainly reflects investor concerns about operational execution and reduced market focus on the near-term urgency of supply chains outside China as the geopolitical environment stabilizes. At the same time, long-only funds recorded cumulative net inflows of US$0.6 billion over the past 12 months, while active long-only fund holdings also increased over the past 3 months. BofA therefore believes the valuation pullback has made the risk-reward increasingly attractive. The target price adjustment reflects lower earnings forecasts rather than a change in the long-term rating. BofA lowers its 12-month target price by A$2.00/share to A$21.00 and its corresponding U.S. dollar target price by US$1.10/share to US$14.50; the previous target prices were A$23.00 and US$15.60, respectively. The target price uses a blended valuation of 1.3x P/NPV and 20x FY31E EV/EBITDA. NAV is calculated using an 8.0% WACC, while FY31 EBITDA valuation is discounted back to the present using the same WACC. The 20x multiple is broadly consistent with global rare earth coverage, and the rare earth peers listed in the report currently trade within a FY27 EV/EBITDA range of 17-35x. The body of the report subsequently uses 1.5x P/NPV to explain the basis for a scarcity premium, including Lynas's position in scaled production of NdPr and Dy/Tb outside China, the strategic importance of rare earths amid Chinese export controls, and policy support from the United States, Australia, and Japan. Despite acknowledging operational ramp-up and CEO transition risks, BofA reiterates its Buy rating.

Analysis framework

BofA first compares FY26 adjusted and reported results with consensus expectations, identifying operating costs, depreciation and amortization, and financing expenses as the sources of the earnings shortfall. It then adjusts cost, EBITDA, and EPS forecasts item by item based on fixed-cost absorption, the assumption that production reaches 12kt in FY29, and changes in lease liabilities. The report subsequently combines NdPr prices, the JARE price floor, production assumptions, and changes in consensus expectations to explain the divergence between earnings expectations and valuation trends. Finally, it determines the 12-month target price through a blended P/NPV, NAV, and EV/EBITDA valuation, supplemented by peer multiples and fund-flow data to validate market positioning.

Methodology notes

• Valuation methodologyNAV methodology

  NAV and P/NPV valuation

  The report calculates the company's net asset value using an 8.0% WACC and uses a P/NPV multiple to reflect the market price relative to project net present value. The blended target-price valuation applies 1.3x P/NPV, while the scarcity-premium discussion in the body separately mentions 1.5x P/NPV.

• Valuation methodologyEV/EBITDA valuation

  FY31 EV/EBITDA comparable valuation

  The report applies 20x EV/EBITDA to forecast FY31 EBITDA and then discounts it back to the present using Lynas's WACC. This multiple is broadly consistent with global rare earth coverage and is compared with the peer FY27 range of 17-35x.

• Industry/sector analysis frameworkVolume-price decomposition

  Decomposition of NdPr prices, production volumes, and unit costs

  The report separately examines rising NdPr prices, the JARE price floor, lower production forecasts, and higher unit costs to explain why price support can offset part of the volume and cost pressure.

• Event-driven analysis and behavioral financeFund flow/positioning analysis

  Long-only fund flows and changes in active holdings

  The report cites cumulative inflows of US$0.6 billion over the past 12 months and increased holdings by active long-only funds over the past 3 months to assess changes in institutional investor allocation to Lynas.

• (Method outside the vocabulary)

  BofA iQmethod standardized indicator system

  The report uses standardized operating performance, earnings quality, and valuation metrics and extracts historical and forecast income statement, balance sheet, and cash flow data from the analyst model database to maintain consistency in cross-company comparisons.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Lynas Rare Earths (LYC.AU; LYSCF/LYSDY)

  The report regards it as a key listed producer in the rare earth supply chain outside China that can benefit from the strategic importance of rare earths, green-economy demand, and policy support from multiple countries.

  Strengths

  Owns the high-grade Mt Weld mine, has established light rare earth separation capabilities, is constructing a heavy rare earth separation facility, and benefits from existing infrastructure, market position, and access to low-cost financing.

  Weaknesses

  Operational disruptions at Kalgoorlie and Mt Weld have raised ramp-up costs, fixed costs temporarily cannot be fully absorbed based on nameplate capacity, and depreciation, amortization, and financing expenses are also above previous forecasts.

  Comparison

  The report describes it as the only listed rare earth producer of meaningful scale outside China and one of the few established companies outside China capable of producing both NdPr and Dy/Tb. The 20x FY31 EV/EBITDA multiple is broadly consistent with the rare earth peer FY27 range of 17-35x.

  Risks

  Rare earth prices or NdPr production may fall below expectations; commissioning or ramp-up of the Dy/Tb project may be delayed; operational execution may underperform; the CEO transition may create uncertainty; and government funding support may be unavailable.

Key data

• FY26 adjusted EBITDAA$402 millionBroadly in line with consensus; reported EBITDA was A$386 million.
• FY26 net profit after taxA$222 million8% below consensus due to operating costs, depreciation and amortization, and financing expenses.
• Forecast average TREO unit cash costA$40/kgRaised by 4.0% from the previous forecast.
• Long-term NdPr production modelingReaches 12kt in FY29Fixed costs cannot be fully absorbed based on nameplate capacity before this production level is reached.
• FY27-FY30 EBITDA forecast revisionLowered by 1%-5%Reflects the operational ramp-up and insufficient fixed-cost absorption.
• FY27-FY30 EPS forecast revisionLowered by an average of 12.0%Primarily due to higher depreciation, amortization, and financing expenses.
• FY27-FY29 EPS forecastsA$0.52 / A$0.58 / A$0.63Previously A$0.59, A$0.65, and A$0.74, respectively.
• FY27-FY29 EBITDA forecastsA$764.8 million / A$970.3 million / A$1,085.0 millionPreviously A$788.1 million, A$984.5 million, and A$1,140.4 million, respectively.
• FY27-FY30 EPS CAGR14%BofA's model-based expectation for medium-term earnings growth.
• Change in NdPr spot pricesUp 20% year to dateSupports upward revisions to consensus FY27-FY31 EPS.
• JARE price floorUS$110/kgProvides downside protection for rare earth prices and earnings expectations.
• Consensus P/NPV0.94xDown from 1.8x in October 2025.
• 12-month target priceA$21.00 / US$14.50Lowered from A$23.00/US$15.60.
• Target-price valuation parameters1.3x P/NPV, 20x FY31 EV/EBITDA, 8.0% WACCUses a blended P/NPV and EV/EBITDA valuation; the scarcity-premium discussion in the body separately mentions 1.5x P/NPV.
• Rare earth peer valuation range17-35x FY27 EV/EBITDAUsed to compare with the 20x target valuation multiple.
• Cumulative long-only fund flowsNet inflows of US$0.6 billion over the past 12 monthsHoldings by active long-only funds also increased over the past 3 months.

Impact & implications

The report believes higher near-term costs, depreciation and amortization, and financing expenses will depress FY27-FY30 earnings, but higher NdPr prices, JARE price protection, and production growth continue to support medium-term profit expansion. Valuation has declined significantly despite upward revisions to consensus expectations, reflecting market concerns about execution risk and the reduced near-term urgency of supply chains outside China. BofA believes this discount does not yet fully reflect Lynas's scarcity value as an established supplier of both light and heavy rare earths outside China or the policy support it receives, and therefore maintains its Buy rating while lowering the target price.

Risks

• Rare earth prices may be lower than expected.
• Lynas's NdPr production may be lower than expected.
• Commissioning of Dy/Tb heavy rare earth products may be delayed, or disruptions may occur during the ramp-up.
• Lynas may be unable to secure government funding support.
• Operational ramp-up and debottlenecking execution at Kalgoorlie and Mt Weld may fall short of expectations.
• The pending CEO transition may create uncertainty.

What to watch

• Monitor operational debottlenecking progress and the credibility of the company's long-term target of 12ktpa of NdPr.
• Monitor growth in the heavy rare earth business and the commissioning and ramp-up of the Dy/Tb facility.
• Monitor subsequent arrangements regarding feedstock sources and the company's downstream strategy.
• Monitor whether unit costs decline as production rises and fixed costs are better absorbed.
• Monitor NdPr prices and the earnings support from the US$110/kg JARE price floor.
• Monitor progress on the CEO transition and its impact on operational execution.